Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00348972
Status:
COMPLETED
Last Update Posted:
2006-07-06
First Post:
2006-07-04
Brief Title:
Lantus in Prediabetes
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Assessment of Safety and Tolerability of Lantus Insulin Glargine in Subjects With Impaired Fasting Glucose IFG or Impaired Glucose Tolerance IGT
Status:
COMPLETED
Status Verified Date:
2006-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the safety tolerability and efficacy of Lantus insulin glargine in prediabetes IFG or IGT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HOE901 | None | None | None |